NU52PS910248
Cooperative Agreement
Overview
Grant Description
Southeastern National Tuberculosis Center at the University of Florida - The proposal from the Southeastern National Tuberculosis Center (SNTC) will address the public health goal of TB elimination by building on our previous success, our relevant programmatic experience, and relationships as a CDC funded TB Center of Excellence (COE). We will continue to use our experience assisting TB programs and clinicians to implement new technology in a personalized/individualized manner that best fits the needs of the program, clinician, and patient.
We will continue to provide and exceed the amount of training required by the grant. We have and will continue to provide education that uses the most appropriate and latest technology and approaches, as well as expert medical consultation, to US TB programs, as we have over the past 18 years. We will use our perspective as an experienced COE to innovatively link public health-based TB experts with a range of providers serving vulnerable populations at-risk for TB, such as refugees, PLWHIV, and non-US born individuals, in support of CDC efforts to focus on LTBI testing and treatment as a key component of TB elimination in the US.
To fulfill our purpose as a TB COE, these measurable outcomes will allow us to measure progress towards achieving our goals. These outcomes are focused around two strategies: (1) TB knowledge, skills, and abilities: communication, education, and training, and (2) TB patient care management: expert medical consultation. By the end of this project, the COE will achieve all of these outcomes: increased knowledge and skills related to TB and LTBI prevention and control among public health staff and healthcare workers; increased access to and use of TB educational resources; expanded availability and use of expert consultations for provider networks serving populations at high-risk for LTBI and TB; increased understanding of regional and national trends of TB patient care needs; and train the next generation of TB experts.
In this proposal, we demonstrate that we have and will continue to build on our experience and lessons learned over 18 years as a CDC funded TB center. We plan to continue to move forward collaborating with CDC and other TB partners as follows: engage and collaborate frequently with regional, state, and local TB control programs, as well as diverse institutions that serve HIV patients, refugees, and other immigrants, including federally qualified health centers and civil surgeons in the private sector; we will continue to be actively involved and lead national and local TB education meetings; we will further develop our relationship with the US panel physicians and the CDC Division of Global Migration and Quarantine (DGMQ).
TB disproportionately affects minority populations that have historically experienced greater barriers to healthcare services. The SNTC has been committed to serving these populations disproportionately affected by TB and LTBI. Over the last 18 years, we have demonstrated that we have the organizational capacity to implement the approach described throughout this proposal. The SNTC utilizes evidence-based evaluation and performance measurement strategies to monitor our success in achieving short, medium, and long-term goals identified in the needs assessment. This proposal shows our capacity and commitment to developing the capacity of the US TB workforce.
We will continue to provide and exceed the amount of training required by the grant. We have and will continue to provide education that uses the most appropriate and latest technology and approaches, as well as expert medical consultation, to US TB programs, as we have over the past 18 years. We will use our perspective as an experienced COE to innovatively link public health-based TB experts with a range of providers serving vulnerable populations at-risk for TB, such as refugees, PLWHIV, and non-US born individuals, in support of CDC efforts to focus on LTBI testing and treatment as a key component of TB elimination in the US.
To fulfill our purpose as a TB COE, these measurable outcomes will allow us to measure progress towards achieving our goals. These outcomes are focused around two strategies: (1) TB knowledge, skills, and abilities: communication, education, and training, and (2) TB patient care management: expert medical consultation. By the end of this project, the COE will achieve all of these outcomes: increased knowledge and skills related to TB and LTBI prevention and control among public health staff and healthcare workers; increased access to and use of TB educational resources; expanded availability and use of expert consultations for provider networks serving populations at high-risk for LTBI and TB; increased understanding of regional and national trends of TB patient care needs; and train the next generation of TB experts.
In this proposal, we demonstrate that we have and will continue to build on our experience and lessons learned over 18 years as a CDC funded TB center. We plan to continue to move forward collaborating with CDC and other TB partners as follows: engage and collaborate frequently with regional, state, and local TB control programs, as well as diverse institutions that serve HIV patients, refugees, and other immigrants, including federally qualified health centers and civil surgeons in the private sector; we will continue to be actively involved and lead national and local TB education meetings; we will further develop our relationship with the US panel physicians and the CDC Division of Global Migration and Quarantine (DGMQ).
TB disproportionately affects minority populations that have historically experienced greater barriers to healthcare services. The SNTC has been committed to serving these populations disproportionately affected by TB and LTBI. Over the last 18 years, we have demonstrated that we have the organizational capacity to implement the approach described throughout this proposal. The SNTC utilizes evidence-based evaluation and performance measurement strategies to monitor our success in achieving short, medium, and long-term goals identified in the needs assessment. This proposal shows our capacity and commitment to developing the capacity of the US TB workforce.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Florida
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 12/31/23 to 12/31/27 and the total obligations have increased 98229% from $3,750 to $3,687,342.
University Of Florida was awarded
TB COE Grant: Enhancing TB Elimination Efforts
Cooperative Agreement NU52PS910248
worth $3,687,342
from National Center for HIV, Viral Hepatitis, STD, and TB Prevention in January 2022 with work to be completed primarily in Florida United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance.
The Cooperative Agreement was awarded through grant opportunity TB Centers of Excellence for Training, Education and Medical Consultation (COE).
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
1/1/23
Start Date
12/31/27
End Date
Funding Split
$3.7M
Federal Obligation
$0.0
Non-Federal Obligation
$3.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU52PS910248
Additional Detail
Award ID FAIN
NU52PS910248
SAI Number
NU52PS910248-4142563647
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVJ0 CDC NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TUBERCULOSIS PREVENTION
Awardee UEI
NNFQH1JAPEP3
Awardee CAGE
5E687
Performance District
FL-90
Senators
Marco Rubio
Rick Scott
Rick Scott
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Health and Human Services (075-0950) | Health care services | Grants, subsidies, and contributions (41.0) | $1,328,260 | 100% |
Modified: 8/6/25